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Abstract
Background: We tested the hypothesis that disseminated intravascular coagulation (DIC) during the early phase
of post-cardiopulmonary resuscitation (CPR) is associated with systemic inflammatory response syndrome (SIRS),
multiple organ dysfunction syndrome (MODS) and affects the outcome of out-of-hospital cardiac arrest (OHCA)
patients.
Methods: A review of the computer-based medical records of OHCA patients was retrospectively conducted and
included 388 patients who were divided into DIC and non-DIC patients based on the Japanese Association for
Acute Medicine DIC diagnostic criteria. DIC patients were subdivided into two groups: those with and without
hyperfibrinolysis. Pre-hospital factors, platelet count, coagulation and fibrinolysis markers and lactate levels within
24 h after resuscitation were evaluated. The outcome measure was all-cause hospital mortality.
Results: DIC patients exhibited lower platelet counts, prolonged prothrombin time, decreased levels of fibrinogen
and antithrombin associated with increased fibrinolysis than those without DIC. DIC patients more frequently
developed SIRS and MODS, followed by worse outcomes than non-DIC patients. The same changes were observed
in DIC patients with hyperfibrinolysis who showed a higher prevalence of MODS, leading to worse outcome than
those without hyperfibrinolysis. Logistic regression analyses showed that lactate levels predicted hyperfibrinolysis
and DIC is an independent predictor of patient death. Survival probabilities of DIC patients during hospital stay
were significantly lower than non-DIC patients. The area under the receiver operating characteristic curve of DIC for
the prediction of death was 0.704.
Conclusions: The fibrinolytic phenotype of DIC during the early phase of post-CPR more frequently results in SIRS
and MODS, especially in patients with hyperfibrinolysis, and affects the outcome of OHCA patients.
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Background
Whole body ischemia reperfusion due to cardiac arrest
constitutes post-resuscitation syndrome resulting from
microvascular obstruction-induced tissue hypoxia in
many vital organs, which affects the patient’s outcome
[1]. Microvascular obstruction, referred to as the no re-
flow phenomenon, in the brain has been attributed to
intravascular thrombosis during cardiac arrest [1, 2].
Post-resuscitation syndrome is now referred to as post-
cardiac arrest syndrome consisting of four syndromes
including systemic ischemia reperfusion responses and
post-cardiac arrest brain injury [3]. Main pathophysiol-
ogies of the former responses are systemic inflammatory
response syndrome (SIRS) and increased coagulation,
which clinically manifest as tissue hypoxia/ischemia and
multiple organ dysfunctions [3]. Adrie et al. [4] confirmed
that successfully resuscitated cardiac arrest was followed
by SIRS and activation of coagulation, both of which con-
tributed to organ dysfunction, including the brain. Recent
studies have indicated that disseminated intravascular
coagulation (DIC) leads to organ dysfunction and affects
the prognosis of out-of-hospital cardiac arrest (OHCA)
patients [5, 6].
Inflammatory cytokine-initiated activation of tissue-
factor-dependent coagulation, insufficient control of the
anticoagulation pathways, and plasminogen activator
inhibitor-1 (PAI-1)-mediated suppression of fibrinolysis
characterize the pathogenesis of DIC [7]. From the first
report of DIC following cardiac arrest [8], higher levels
of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6)
and IL-8 [4, 9, 10]; increased tissue factor levels [11]; in-
sufficient levels of tissue factor pathway inhibitor (TFPI),
antithrombin, protein C and protein S [4, 11]; and in-
creased PAI-1 levels [12, 13] have been repeatedly con-
firmed during cardiopulmonary resuscitation (CPR) and
after return of spontaneous circulation (ROSC). These
changes lead to massive thrombin generation and con-
secutive fibrin formation [4, 6, 12]. Importantly, under-
lying conditions of DIC occasionally cause a simultaneous
increase in fibrinolysis resulting from tissue-type plas-
minogen activator (t-PA), which is referred to as DIC with
the fibrinolytic phenotype, as opposed to the thrombotic
phenotype associated with elevated PAI-1 levels [14]. Both
types of DIC have been recognized to affect the
patient’s outcome [7, 14].
Marked increases in t-PA antigen and activity levels
were followed by the PAI-1 expression during CPR and
immediately after ROSC within 24 h [12]. In this study,
therefore, significant imbalances between the levels of t-PA
and PAI-1 during the first 24 h after cardiac arrest and
resuscitation was noted which was coincided with the
definition of DIC with the fibrinolytic phenotype.
According to the results of these previous studies on
DIC, we investigated changes in coagulation and fibrinolysis
markers during the first 24 h after OHCA and resusci-
tation. We tested the hypothesis that DIC with the fi-
brinolytic phenotype during the early phase of post-CPR is
associated with SIRS, organ dysfunctions and affects the
patient’s outcome.
Methods
Patient selection and data collection
From June 2000 to December 2011, all consecutive pa-
tients older than 12 years of age with successful ROSC
from OHCA who were admitted to the ICU were eligible
for this study. Patients who suffered to cardiac arrest due
to trauma or burns, those on warfarin therapy, those with
end-stage liver diseases, terminal illnesses or profound
hypothermia, and those underwent percutaneous cardio-
pulmonary support (PCPS) were excluded. The Institu-
tional Review Board of our institution approved this study
and issued a waiver of informed consent.
A systematic review of the computer-based medical re-
cords of these patients was retrospectively conducted to
provide baseline characteristics and DIC-related variables.
Data regarding the platelet count, prothrombin time,
prothrombin time ratio, fibrinogen, antithrombin, fi-
brin/fibrinogen degradation products (FDP), D-dimer
and lactate were obtained at 4 time points within 24 h
after successful ROSC: Time Point 01, immediately
after ROSC to 4 h after ROSC; Time Point 02, 4 to 8 h
after ROSC; Time Point 03, 8 to 16 h after ROSC; and
Time Point 04, 16 to 24 h after ROSC. Day 0 data indi-
cates the highest or lowest values of these 4 points
measurements. Namely, the maximal worst values during
this time period were considered for classfiyng patients
with or without DIC and for determining the phenotype.
The standard practice in our ICU for all patients is to
draw blood several times a day in order to analyze the la-
boratory data including platelet count, coagulation and fi-
brinolysis. Blood gas analyses with lactate measurements
were also frequently performed.
Study setting and definitions
The levels of care provided by the emergency medical
technicians (EMT) in our country are comparable to
other advanced countries worldwide. The management
of cardiac arrest was based on the 2000, 2005, and 2010
guidelines proposed by the International Liaison Commit-
tee on Resuscitation. Detailed pre-hospital care and CPR
methods in our department can be found elsewhere [15].
Successful ROSC was defined as measurable blood
pressure and pulse for more than 1 h and admission to
the ICU, regardless of catecholamine use. Organ dys-
function was assessed by the Sequential Organ Failure
Assessment (SOFA) score [16]. Multiple organ dysfunc-
tion syndrome (MODS) was defined as a SOFA score ≥ 12
[16]. The SIRS score was calculated according to the
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American College of Chest Physicians/Society of Critical
Care Medicine consensus conference [17]. The diagnosis
of DIC was made based on the Japanese Association for
Acute Medicine (JAAM) DIC diagnosis criteria using
day 0 data [18]. When the total score was ≥ 4, the DIC
was established. The DIC phenotype was defined with
reference to the criteria of Asakura, hyperfibrinolysis
was defined as an FDP level of ≥ 100 μg/mL, and the
FDP/D-dimer ratio was used as a surrogate marker of
fibrin (ogen) olysis [14]. Tissue hypoperfusion was defined
as a blood lactate level of ≥ 4 mmol/L based on the Surviv-
ing Sepsis Campaign Guidelines 2012 [19]. The outcome
measure was the hospital all-cause mortality.
Statistical analysis
Data are presented as the median and interquartile range.
The IBM SPSS 22.0 for MAC OSX software program
(IBM Japan, Tokyo) was used for the statistical analyses
and calculations. Comparisons between the two groups
were performed with the Mann-Whitney U test and either
the Chi-square test or Fisher’s exact test when required.
The relationships between the dependent and the inde-
pendent variables were analyzed by a logistic regression
analysis (the backward stepwise method based on likeli-
hood) and the results were reported as the odds ratio and
95 % confidence intervals. The discriminatory perform-
ance for hospital death was evaluated using the area under
the receiver operating characteristic (ROC) curve (AUC).
Survival curves during hospital stay were derived accord-
ing to the Kaplan-Meier methods and compared using the
log-rank test. Differences with p-values <0.05 were consid-
ered to be statistically significant.
Results
Baseline patient characteristics
During the study period, a total of 1243 OHCA patients
presented to our Emergency Department. After the ex-
clusion of ineligible patients and patients with incom-
plete data for calculation of the DIC score, those
performed PCPS were further excluded. Finally, 388 eli-
gible patients were identified, who were divided into
DIC (n = 208) and non-DIC patients (n = 180).
Table 1 shows the demographic data of the patients.
Cardiac arrest due to a cardiac origin was less frequent
in DIC patients. All DIC patients developed SIRS. DIC
patients exhibited higher SIRS and SOFA scores associ-
ated with MODS, which associated with a significantly
higher mortality than non-DIC patients (54.8 % vs.
23.9 %). Although some data were lacking (DIC, n = 182;
Non DIC, n = 163), the Acute Physiology and Chronic
Table 1 Demographic and clinical characteristics of all patients
Non DIC DIC p Value
(180) (208)
Age (year) 66 (55–76) 71 (58–80) 0.020
Male sex (n,%) 112 (62.2) 124 (59.6) 0.604
Causes of cardiac arrest
CNS/Cardiac/Respiratory/Asphyxia/Other/Unknown 13/99/24/32/11/1 18/86/30/37/32/5 –
Cardiac (n,%) 99 (55.0) 86 (41.3) 0.008
Initial rhythm
VF/Asystole/PEA/Pulseless VT/Unknown 32/41/33/3/71 24/75/35/6/24 –
Shockable rhythm (n,%) 35 (19.4) 30 (14.4) 0.220
Witnessed arrest 75 (41.7) 92 (44.2) 0.681
Bystander CPR (n,%) 55 (30.6) 50 (24.0) 0.169
Shock by EMT (n,%) 42 (23.3) 44 (21.1) 0.626
Therapeutic hypothermia (n,%) 44 (24.4) 40 (19.2) 0.219
DIC score 2 (1–2) 5 (4–6) 0.000
SIRS score 3 (3–4) 4 (3–4) 0.048
SIRS (n,%) 178 (98.9) 208 (100) 0.215
SOFA day 0 score 6 (4–8) 9 (6–11) 0.000
MODS day 0 (n,%) 7 (3.9) 49 (23.6) 0.000
MODS day 5 (n,%) 10 (5.5) 67 (32.2) 0.000
Outcome death (n,%) 43 (23.9) 114 (54.8) 0.000
CNS central nervous system, VF ventricular fibrillation, PEA pulseless electrical activity, VT ventricular tachycardia, CPR cardiopulmonary resuscitation,
EMT emergency medical technician, DIC disseminated intravascular coagulation, APACHEII Acute Physiology and Chronic Health Evaluation II, SIRS systemic
inflammatory response syndrome, SOFA sequential organ failure assessment, MODS multiple organ dysfunction syndrome
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Health Evaluation II scores of the DIC patients [34
(29–38)] were significantly higher than those of the non-
DIC patients [29 (24–33)] (P < 0.001), suggesting that
conditions of the DIC patients were more severe.
Serial changes in measured variables
DIC patients continuously showed lower platelet counts,
more prolonged prothrombin time ratios, and lower
levels of fibrinogen and antithrombin than non-DIC pa-
tients (Fig. 1). Extremely high levels of FDP and D-dimer
associated with marked increases in lactate levels were
also observed in DIC patients (Fig. 2). In addition, FDP/
D-dimer ratios in DIC patients were significantly higher
than in non-DIC patients (Fig. 3). These results suggest
consumption coagulopathy, insufficient anticoagulation,
fibrin (ogen) olysis, and tissue hypoperfusion in DIC pa-
tients and that the DIC belongs to the fibrinolytic
phenotype. The numbers of patients at each time point
are provided in Additional file 1: Table S1.
Subgroup analyses of DIC patients
DIC patients were subdivided into those with (n = 73)
and without (n = 135) hyperfibrinolysis (Table 2). The
markers of fibrinolysis and lactate levels of DIC patients
with hyperfibrinolysis are presented in Table 3. Patients
with hyperfibrinolysis had higher DIC and SOFA scores.
Furthermore, MODS in these patients continued from
day 0 to day 5, leading to a higher mortality rate of
68.5 % in comparison to patients without hyperfibrinoly-
sis (41.7 %). The median FDP/D-dimer ratio of 2.0 in pa-
tients with hyperfibrinolysis was significantly higher than
that in those without hyperfibrinolysis (Table 3). In
addition, the lactate levels were significantly higher in
those with hyperfibrinolysis than in those without fibrin-
olysis. These results suggest that DIC with hyperfibrinolysis
is considered to be more severe DIC associated with ex-
treme fibrin (ogen) olysis and tissue hypoperfusion, which
results in worse outcome.
Outcome analyses
Stepwise logistic regression analyses confirmed that DIC,
SOFA scores, and lactate levels are independent predic-
tors of patient death (Table 4). Hyperfibrinolysis also
predicted patient death (Table 5). Table 5 shows that tis-
sue hypoperfusion (as indicated by lactate level) is one
of the causes of hyperfibrinolysis. ROC curves showed a
significant discriminative performance of DIC and SOFA
scores and lactate levels for patient death (Fig. 4). These
Fig. 1 Box plots showing serial changes in the platelet counts, prothrombin time ratios, fibrinogen and antithrombin levels during the first 24 h
in successfully resuscitated patients after OHCA. DIC patients (grey boxes) showed significantly lower platelet counts, more prolonged prothrombin
time ratios, lower levels of fibrinogen and antithrombin than non-DIC patients (open boxes). Horizontal bars in the box indicate the median (middle)
and interquartile ranges (upper 25 %, lower 75 %). Black squares in the box indicate the mean value. Top and bottom bars indicate the maximum and
minimum values, respectively. *p < 0.001 vs. non-DIC patients
Wada et al. Thrombosis Journal  (2016) 14:43 Page 4 of 9
results are important because the DIC score (score of
one organ dysfunction [blood]) showed good discrimina-
tive power for the outcome compared with the SOFA
score (score of multiple organ dysfunction). Kaplan-Meier
curves showed that DIC, especially DIC with hyperfibrino-
lysis, significantly affected patient death (Fig. 5).
Discussion
The results of the present study demonstrate that OHCA
patients with DIC during the early phase of post CPR are
at risk of SIRS and MODS and that their condition is asso-
ciated with a poor prognosis. The markedly higher FDP
and D-dimer levels, and FDP/D-dimer ratio indicate that
this type of DIC belongs to DIC with the fibrinolytic
phenotype accompanied by fibrin (ogen) olysis. The out-
comes of DIC patients with hyperfibrinolysis were worse
than those observed in DIC patients without hyperfibrino-
lysis. The results of the logistic regression analyses suggest
Fig. 2 Box plots showing serial changes in FDP, D-dimer and lactate
levels. DIC patients (grey boxes) showed significantly higher values of
three variables than non-DIC patients (open boxes). Horizontal bars
in the box indicate the median (middle) and interquartile ranges
(upper 25 %, lower 75 %). Black squares in the box indicate the mean
value. Top and bottom bars indicate the maximum and minimum
values, respectively. *p < 0.001 vs. non-DIC patients
Fig. 3 Box plots showing FDP/D-dimer ratios between DIC (grey
boxes) and non-DIC patients (open boxes). DIC patients exhibited
significantly higher ratios than non-DIC patients. Horizontal bars in
the box indicate the median (middle) and interquartile ranges
(upper 25 %, lower 75 %). Black squares in the box indicate the
mean value. Top and bottom bars indicate the maximum and
minimum values, respectively. *p < 0.001 vs. non-DIC patients
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that tissue hypoperfusion, as evaluated by the lactate level,
may be a cause of increased fibrinolysis.
Kim et al. [5] found that an increased initial DIC score
in OHCA patients was an independent predictor for
poor outcomes and early mortality risk. OHCA patients
with a higher D-dimer level on admission had a poor
outcome and the D-dimer levels were independent pre-
dictor of mortality [20]. Although hyperfibrinolysis was
assessed by maximum lysis of rotational thromboelasto-
metry, OHCA patients associated with hyperfibrinolysis
showed a higher mortality rate, and hyperfibrinolysis
was correlated with markers of tissue hypoperfusion
including pH, base excess and lactate levels [21, 22].
Cardiac arrest due to asphyxia by drowning developed
DIC with the fibrinolytic phenotype was associated
with lower platelet counts and fibrinogen levels, prolonged
prothrombin time, and significantly higher D-dimer levels,
which led to a worse outcome [23]. The present study has
importance in that it validates the previous studies, which
separately confirmed the importance of DIC or increased
fibrinolysis, and provides a unified concept of DIC with
the fibrinolytic phenotype. It also reveals that this DIC
phenotype is associated with an increased risk of mortality,
especially those with hyperfibrinolysis.
For a long time, anoxia and endothelial injury were
believed to be clearly established triggering stimuli for
the appearance of circulating fibrinolytic activator and







Age (year) 70 (58–79) 73 (59–82) 0.091
Male sex (n,%) 78 (57.8) 46 (63.0) 0.554
Causes of cardiac arrest
Cardiac (n,%) 54 (40.0) 32 (43.8) 0.659
Initial rhythm
Shockable rhythm (n,%) 22 (16.3) 8 (11.0) 0.408
Witnessed arrest 59 (43.7) 33 (45.2) 0.884
Bystander CPR (n,%) 28 (20.7) 22 (30.1) 0.173
Shock by EMT (n,%) 27 (20.0) 17 (23.3) 0.597
Therapeutic hypothermia (n,%) 30 (22.2) 10 (13.7) 0.146
DIC score 5 (4–5) 5 (4.5–6) 0.000
SIRS score 3 (3–4) 4 (3–4) 0.359
SIRS (n,%) 135 (100) 73 (100) –
SOFA day 0 score 8 (6–11) 10 (7–13) 0.001
MODS day 0 (n,%) 23 (17.0) 26 (35.6) 0.004
MODS day 5 (n,%) 36 (26.7) 31 (42.5) 0.029
Outcome death (n,%) 64 (47.4) 50 (68.5) 0.004
CNS central nervous system, VF ventricular fibrillation, PEA pulseless electrical activity, VT ventricular tachycardia, CPR cardiopulmonary resuscitation,
EMT emergency medical technician, DIC disseminated intravascular coagulation, SIRS systemic inflammatory response syndrome, SOFA sequential organ failure
assessment, MODS multiple organ dysfunction syndrome
Table 3 Markers of fibrinolysis and lactate levels between DIC






FDP (μg/mL) 42.5 (28.2–57.6) 186.0 (110.3–404.5) 0.000
D-dimer (μg/mL) 20.3 (14.4–28.2) 74.3 (49.9–182.5) 0.000
FDP/D-dimer 1.8 (1.5–2.5) 2.0 (1.7–2.9) 0.007
Lactate (mmol/L) 8.1 (5.3–11.1) 11.3 (8.5–15.6) 0.000
Day 0 data are used for the FDP, D-dimer, and FDP/D-dimer values. The lactate
data was obtained using data from time point 01
Table 4 Stepwise logistic regression analyses for prediction of
the outcome (death)
Odds ratio p Value 95 % confidence interval
DIC score 1.171 0.041 1.006–1.364
SOFA score 1.178 0.001 1.073–1.292
Lactate 1.129 0.000 1.065–1.0197
Witnessed arrest 0.637 0.081 0.385–1.057
Cardiac origin 0.449 0.003 0.266–0.756
Shockable rhythm 0.400 0.024 0.180–0.887
The results of the final step of the analyses are shown. The dependent
variables on the first steps: age, sex, DIC score (day 0), SOFA score (day 0),
SIRS score (day 0), lactate level (time point 01), witnessed arrest, bystander
CPR, shock by EMT, cardiac origin, and shockable rhythm
DIC disseminated intravascular coagulation, SOFA sequential organ failure
assessment, SIRS systemic inflammatory response syndrome, CPR cardiopulmonary
resuscitation, EMT emergency medical technician
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increased fibrinolysis [24–26]. Schneiderman et al. [27, 28]
confirmed immediate increases in t-PA activity following
arterial occlusion-induced ischemia both in humans
and a rat model, which is attributable to the release of
preexisting t-PA in Weibel-Palade bodies [29]. PAI-1
mRNA is initially expressed 4 h after hypoxia, followed
by the appearance of PAI-1 antigen at 6 h, and reaches
its peak levels at 20 to 24 h after hypoxia [30]. These
chronological changes in the levels of t-PA and PAI-1
completely coincide with the changes in these variables
during CPR and after ROSC in patients with OHCA [12].
These results suggest that hypoxia during pre-cardiac
arrest, and ischemia/hypoxia during cardiac arrest and
CPR result in whole body tissue hypoperfusion recognized
as increased lactate levels, which is followed by increased
fibrinolysis in DIC patients, as observed in the present and
our previous study and asphyxia-induced OHCA patients
[12, 23].
There are pre-cardiac arrest differences in the perfusion
pressure and blood flow and the duration and degree of
tissue hypoperfusion, which is dependent on the cause of
cardiac arrests, such as shock, exsanguination, asphyxia,
and ventricular fibrillation [1]. Ventricular fibrillation indi-
cates sudden onset of ischemia without pre-cardiac arrest
Table 5 Logistic regression analyses for prediction of the
outcome (death) and hyperfibrinolysis in DIC patients
Odds ratio p Value 95 % confidence
interval
Outcome (enter method)
SOFA score 1.204 0.000 1.094–1.324
Hyperfibrinolysis 1.938 0.038 1.036–3.626
Hyperfibrinolysis (stepwise method)
Age 1.002 0.030 1.002–1.043
Bystander CPR 0.536 0.083 0.265–1.085
Lactate on time point 01 1.129 0.000 1.062–1.196
The stepwise method shows the results of the final step of the analyses. The
dependent variables on the first steps: age, sex, lactate level, witnessed arrest,
bystander CPR, shock by EMT, cardiac origin, and shockable rhythm
DIC disseminated intravascular coagulation, SOFA sequential organ failure
assessment, CPR cardiopulmonary resuscitation, EMT emergency
medical technician
Fig. 4 ROC curves of the DIC scores (blue line), SOFA scores (green line)
and lactate levels (yellow line) for the prediction of hospital death of
OHCA patients. All of these variables showed a good discriminative
power to predict poor outcome of the patients. SE, standard error
Fig. 5 Kaplan-Meier curves showing the association between DIC (a)
or hyperfibrinolysis (b) with hospital mortality. DIC and DIC with
hyperfibrinolysis showed a significantly lower survival probability in
the hospital than non-DIC patients and DIC without hyperfibrinolysis
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hypoxia. Therefore, in the present study, a low incidence
of cardiac arrest due to a presumed cardiac origin in DIC
patients might, in part, explain the finding that causes of
cardiac arrest influence the degree of fibrinolysis. How-
ever, a subgroup analysis of a previous study confirmed
that the magnitude of increased risk of a DIC-dependent
poor prognosis in cardiac etiology was similar to that of
the overall study population [5]. Many studies have re-
ported that the time to first basic life support and duration
of CPR were two of the main causes of hyperfibrinolysis
[5, 21–23]. Although these parameters were not obtained
in the present study, low odds ratio of bystander CPR in
Table 5 indirectly suggests that a shortened ischemia
period due to bystander CPR may reduce the risk of
hyperfibrinolysis. Lastly, evenly distributed therapeutic
hypothermia excluded the effects of hypothermia on DIC
and increased fibrinolysis in the present study. Taken to-
gether, these results suggest that the duration of hypoxia/
ischemia, but not etiologies of cardiac arrest, may be a
primary determinant of the development of DIC with
the fibrinolytic phenotype in OHCA patients.
Activated protein C did not increase in OHCA patients
[22]. Another study confirmed that activated protein C
levels are not high enough to inhibit PAI-1 [23]. Neither
syndecan-1 nor endothelial heparin sulfate levels were
elevated in DIC with the fibrinolytic phenotype ob-
served in asphyxia-induced OHCA [23]. Furthermore,
other heparinase-sensitive glycosaminoglycans were not
elevated [23]. These results suggest that participations
of activated protein C and phenomena referred to as
auto-heparinization are highly unlikely during hyperfi-
brinolysis in patients with OHCA.
Limitations. The results of the present study is based
on retrospective analyses of OHCA in a single center and
limited by an incomplete data set. Although increased fi-
brinolysis can be confirmed, the supposed causes of this
phenomenon, such as t-PA and PAI-1, were not measured.
Bleeding or a bleeding tendency, and the time to ROSC,
and outcome scores such as cerebral performance cat-
egory were not evaluated due to a lack of data. However,
the magnitude of the results of this study suggests that a
prospective multicenter study is needed to evaluate the
effect of DIC on the outcome of OHCA patients.
Conclusions
In OHCA patients, DIC during the early phase of post-
CPR exhibited lower platelet counts, consumption coagu-
lopathy, and insufficient antithrombin levels associated
with increased fibrin (ogen) olysis assessed by higher FDP/
D-dimer ratios, which can explain DIC of the fibrinolytic
phenotype. DIC patients, especially those with hyperfibri-
nolysis, more gives rise to MODS associated with SIRS,
leading to worse outcomes than those without DIC. Tissue
hypoperfusion due to hypoxia and ischemia during cardiac
arrest and CPR may be considered to be one of the causes
of increased fibrinolysis in this type of DIC. The present
study has validated previous studies that separately con-
firmed existence of DIC or increased fibrinolysis during
the early post-CPR phase in OHCA patients. This study
has further importance in that it unifies DIC and increased
fibrinolysis as a single condition in the fibrinolytic
phenotype of DIC and it recognized that this phenotype
is associated with poor outcome.
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Additional file 1: Table S1. Numbers of the patients. (DOCX 48 kb)
Abbreviations
CNS: Central nervous system; CPR: Cardiopulmonary resuscitation;
DIC: Disseminated intravascular coagulation; EMT: Emergency medical
technician; FDP: Fibrin/fibrinogen degradation products; MODS: Multiple
organ dysfunction syndrome; OHCA: Out-of-hospital cardiac arrest;
PCPS: Percutaneous cardiopulmonary support; PEA: Pulseless electrical
activity; ROSC: Return of spontaneous circulation; SIRS: Systemic inflammatory
response syndrome; SOFA: Sequential organ failure assessment;




Departmental funding was used for this study.
Availability of data and materials
The datasets supporting the conclusions of this article are available in the
[FigShare] repository [unique persistent identifier and hyperlink to dataset(s)
in https://figshare.com/articles/Data_set1_xlsx/3122110].
Authors’ contributions
TW designed the study, interpreted the data, and drafted the manuscript.
SG conceived the study, analyzed and interpreted the data, and drafted the
manuscript. YO, KM, KK, MH, and AS participated in the study design, helped
to draft the manuscript, and proofread the manuscript. All authors read and
approved the final manuscript.
Competing interests
Gando S received payment for lectures from Asahi Kasei Pharma. The other
authors declare that they have no conflict of interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
The Institutional Review Board of our institution (Hokkaido University
Hospital Clinical Research and Medical Innovation Center) approved this
study (No. 012–0035) and issued a waiver of informed consent.
Received: 28 July 2016 Accepted: 30 August 2016
References
1. Safer P, Bircher NG. Prolonged life support. Cardiopulmonary cerebral
resuscitation. Basic and advanced cardiac and trauma life support. In: Safer
P, Bircher NG, editors. An introduction to resuscitation medicine. 3rd ed.
Philadelphia: Saunders Company; 1988. p. 229–78.
2. Fisher M, Hossmann KA. No-reflow after cardiac arrest. Intensive Care Med.
1995;21:132–41.
3. Neumar RW, Nolan JP, Adrie C, Aibiki M, Berg RA, Böttiger BW, et al. Post-
cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and
prognostication. A consensus statement from the International Liaison
Wada et al. Thrombosis Journal  (2016) 14:43 Page 8 of 9
Committee on Resuscitation (American Heart Association, Australian and
New Zealand Council on Resuscitation, European Resuscitation Council,
Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation,
Resuscitation Council of Asia, and the Resuscitation Council of Southern
Africa); the American Heart Association Emergency Cardiovascular Care
Committee; the Council on Cardiovascular Surgery and Anesthesia; the
Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on
Clinical Cardiology; and the Stroke Council. Circulation. 2008;118:2452–83.
4. Adrie C, Monchi M, Laurrent I, Um S, Yan SB, Thuong M, et al. Coagulopathy after
successful cardiopulmonary resuscitation following cardiac arrest. Implication of
the protein C anticoagulant pathway. J Am Coll Cardiol. 2005;46:21–8.
5. Kim J, Kim K, Lee JH, Jo YH, Kim T, Rhee JE, et al. Prognostic implication of initial
coagulopathy in out-of-hospital cardiac arrest. Resuscitation. 2013;84:48–53.
6. Wada T, Gando S, Mizugaki A, Yanagida Y, Jesmin S, Yokota H, et al.
Coagulofibrinolytic changes in patients with disseminated intravascular
coagulation associated with post-cardiac arrest syndrome – Fibrinolytic
shutdown and insufficient activation of fibrinolysis lead to organ
dysfunction. Thromb Res. 2013;132:e64–9.
7. Levi M, ten Cate H. Disseminated intravascular coagulation. N Engl J Med.
1999;341:586–92.
8. Mehta B, Briggs DK, Sommers SC, Karpatkin M. Disseminated intravascular
coagulation following cardiac arrest: a study of 15 patients. Am J Med Sci.
1972;264:353–63.
9. Hayakawa H, Sawamura A, Yanagida Y, Sugano M, Kubota M, Hoshino H, et
al. Insufficient production of urinary trypsin inhibitor for neutrophil elastase
release after cardiac arrest. Shock. 2008;29:549–52.
10. Shyu KG, Chang H, Lin CC, Huang FY, Hung CR. Concentrations of serum
interleukin-8 after successful cardiopulmonary resuscitation in patients with
cardiopulmonary arrest. Am Heart J. 1997;134:551–6.
11. Gando S, Nanzaki S, Morimoto M, Kobayashi S, Kemmotsu O. Tissue factor
and tissue factor pathway inhibitor levels during and after cardiopulmonary
resuscitation. Thromb Res. 1999;96:107–13.
12. Gando S, Kameue T, Nanzaki S, Nakanishi Y. Massive fibrin formation with
consecutive impairment of fibrinolysis in patients with out-of-cardiac arrest.
Thromb Haemost. 1997;77:278–82.
13. Geppert A, Zorn G, Delle-Karth G, Heinz G, Murer G, Siostrzonik P, et al.
Plasminogen activator inhibitor type 1 and outcome after successful
cardiopulmonary resuscitation. Crit Care Med. 2001;29:1670–7.
14. Asakura H. Classifying types of disseminated intravascular coagulation:
clinical and animal models. J Intensive Care. 2014;2:20.
15. Ono Y, Hayakawa M, Wada T, Sawamura A, Gando S. Effects of prehospital
epinephrine administration on neurological outcomes in patients with out-
of-hospital cardiac arrest. J Intensive Care. 2015;3:29.
16. Ferreira FL, Bota DP, Bross A, Mélot C, Vincent JL. Serial evaluation of the SOFA
score to predict outcome in critically ill patients. JAMA. 2001;286:1754–8.
17. Members of the American College of Chest Physicians/Society of Critical
Care Medicine Consensus Conference committee. American College of
Chest Physicians/Society of Critical Care Medicine Consensus Conference.
Definition for sepsis and organ failure and guidelines for the use innovative
therapies in sepsis. Crit Care Med. 1992;20:864–74.
18. Gando S, Saitoh D, Ogura H, Mayumi T, Koseki K, Ikeda T, et al. Japanese
Association for Acute Medicine disseminated intravascular coagulation
(JAAM DIC) study group. Natural history of disseminated intravascular
coagulation diagnosed based on the newly established diagnostic criteria
for critically ill patients: Results of a multicenter, prospective survey. Crit
Care Med. 2008;36:145–50.
19. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al.
Surviving sepsis campaign: international guidelines for management of
severe sepsis and septic shock: 2012. Crit Care Med. 2013;41:580–637.
20. Szymanski FM, Karpinski G, Filipiak KJ, Platek AE, Hrynkiewicz-Szymanska A,
Kotkowski M, et al. Usefulness of the D-dimer concentration as a predictor
of mortality in patients with out-of-hospital cardiac arrest. Am J Cardiol.
2013;112:467–71.
21. Viersen VA, Greuters S, Korfage AR, Van der Rijst C, Van Bochove V,
Nanayakkara PW, et al. Hyperfibrinolysis in out of cardiac arrest is associated
with markers of hypoperfusion. Resuscitation. 2012;83:1451–5.
22. Duvekot A, Viersen VA, Dekkar SE, Geeraedts LMG, Schwarte LA, Spoelstra-Man
AME, et al. Low cerebral oxygenation levels during resuscitation in out-of-hospital
cardiac arrest are associated with hyperfibrinolysis. Anesthesiology. 2015;123:820–9.
23. Schwameis M, Schober A, Schörgenhofer C, Sperr WR, Schöchl H, Janata-
Schwatczek K, et al. Asphyxia by drowning induces massive bleeding
due to hyperfibrinolytic disseminated intravascular coagulation. Crit Care
Med. 2015;43:2394–402.
24. Clearke RL, Clifton EE. Oxygen saturation and spontaneous fibrinolytic
activity. Am J Med Sci. 1962;244:466–71.
25. Todd AS. Endothelium and fibrinolysis. Atherosclerosis. 1972;15:137–40.
26. Bätsch P, Haeberli A, Hauser K, Gubser A, Straub PW. Fibrinogenolysis in the
absence of fibrin formation in severe hypobaric hypoxia. Aviat Space
Environ Med. 1988;59:428–32.
27. Schneiderman J, Adar R, Savion N. Changes in plasmatic tissue-type
plasminogen activator and plasminogen activator inhibitor activity during
acute arterial occlusion associated with ischemia. Thromb Res. 1991;62:401–8.
28. Schneiderman J, Eguchi Y, Adar R, Sawdey M. Modulation of fibrinolytic
system by major peripheral ischemia. J Vasc Surg. 1994;19:516–24.
29. Lowenstein CJ, Morrell CN, Yamakuchi M. Regulation of Weibel-Palde body
exocytosis. Trend Cardiovasc Med. 2005;15:302–8.
30. Pinsky DJ, Liao H, Lawson CA, Yan SF, Chen J, Cameliet P, et al. Coordinated
induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of
plasminogen activator gene expression by hypoxia promotes pulmonary
vascular fibrin deposition. J Clin Invest. 1998;102:919–28.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Wada et al. Thrombosis Journal  (2016) 14:43 Page 9 of 9
